The Weight-Loss Battle That Could Rattle Eli Lilly's $100 Billion …

Dec 5, 2024  · Eli Lilly stock tumbled more than 6% on Oct. 30 after sales of Mounjaro and Zepbound missed third-quarter expectations. The duo generated a combined $4.37 billion in …


Install CouponFollow Chrome Extension   CouponFollow Extension

6%
OFF

The Weight-Loss Battle That Could Rattle Eli Lilly's $100 Billion …

3 weeks from now

Dec 5, 2024  · Eli Lilly stock tumbled more than 6% on Oct. 30 after sales of Mounjaro and Zepbound missed third-quarter expectations. The duo generated a combined $4.37 billion in …

investors.com

$70
OFF

Eli Lilly Stock Higher Following Surprise Weight Loss Treatment Data

3 weeks from now

Dec 4, 2024  · Analysts see the market for GLP-1 weight loss treatments rising to around $70 billion over the next five years.

thestreet.com

$2.49
OFF

Analysts Revamp Eli Lilly Stock Price Target On Weight-loss Drugs

3 weeks from now

Feb 7, 2024  · Eli Lilly reported fourth-quarter income of $2.49 a share, beating the FactSet consensus of $2.30. Revenue totaled $9.35 billion, ahead of Wall Street's call for $8.9 billion in …

yahoo.com

$9
OFF

Eli Lilly's Weight-Loss Drugs Fuel Beat-And-Raise Quarter

3 weeks from now

Aug 8, 2024  · Eli Lilly's results handily beat analysts' expectations. Wall Street was anticipating revenue of $9.9 billion and earnings of $2.60 per share, according to Yahoo Finance.. As a …

kiplinger.com

$8
OFF

Eli Lilly Stock Surges On Demand For Weight-Loss Drugs

3 weeks from now

Apr 30, 2024  · The Q1 results were mixed compared with analysts' expectations, which called for revenue of $8.9 billion and EPS of $2.46, according to Yahoo Finance.. Still, Eli Lilly's weaker …

kiplinger.com

50%
OFF

Eli Lilly (LLY) Stock Up Almost 50% Year To Date: Here's Why

3 weeks from now

Aug 17, 2023  · The stock has risen 49.3% so far this year compared with an increase of 8.1% for the industry.. Image Source: Zacks Investment Research. Strong Q2 Results and Raised Outlook

nasdaq.com

$130
OFF

Eli Lilly Stock Has Quadrupled In 3 Years. Could A Weight-Loss

3 weeks from now

Oct 31, 2023  · Lilly stock has raced from a price of $130 per share at this time of year in 2020 to $568 now, peeling back just a bit from its early October record high of $629.97. Call it the Eli …

nasdaq.com

4%
OFF

Novo Crashes After Obesity Drug Misses Lofty Expectations. Lilly

3 weeks from now

Eli Lilly stock rose 1.4% to 767.76, while Viking Therapeutics shares ran up 1.8% to 42.25. ... Novo had lofty expectations for at least 25% weight loss from the combination approach.

msn.com

$81
OFF

Eli Lilly Stock And The Road To 1,000: The $81 Billion Weight-Loss ...

3 weeks from now

Mar 1, 2024  · Eli Lilly's new weight-loss drug could generate more than $62 billion in 2030 sales, an analyst said Friday as he boosted his price target on Eli Lilly stock to 1,000. ↑ X

investors.com

160%
OFF

Why Eli Lilly Stock's Big Jump Last Week Could Be Just The

3 weeks from now

Aug 13, 2024  · For a while, it seemed the streak was over for Eli Lilly (NYSE: LLY). Shares of the big drugmaker skyrocketed nearly 160% between early 2023 and mid-July of this year. …

nasdaq.com

33%
OFF

Novo Nordisk Raises Expectations For Eli Lilly After CagriSema …

3 weeks from now

After the setback, Eli Lilly shares climbed, adding to its ~33% gains over the past 12 months, a period NVO has lost ~17% amid industry challenges such as supply constraints for its weight …

msn.com

31%
OFF

Elon Musk Weighs In On Weight-Loss Drug Stocks. Is LLY Or NVO A …

3 weeks from now

Eli Lilly’s stock was a strong performer in 2024, thanks to its GLP-1 drugs. Over the past 52 weeks, the stock is up 31%, and over the past five years, it has gained an impressive 460%.

msn.com

770%
OFF

Think Eli Lilly Stock Has Peaked? These 10 Words From The CEO

3 weeks from now

Aug 30, 2024  · Eli Lilly (NYSE: LLY) stock is up a mammoth 770% in five years. It is trading at new all-time highs in 2024 thanks to the incredible success and popularity of its diabetes and …

nasdaq.com

38%
OFF

Eli Lilly Stock Soars As FDA Ends Weight Loss Drug Shortage

3 weeks from now

Dec 20, 2024  · How This Affects LLY Stock. LLY investors are celebrating today’s FDA news as it protects Eli Lilly’s sales of its GLP-1 drugs. With that comes an 8.38% increase in share price …

nasdaq.com

58%
OFF

Eli Lilly Stock Could Soar To $1,150, According To A Wall Street

3 weeks from now

S hares of Eli Lilly (NYSE: LLY) have already soared by about 58% in 2024. Despite the run-up, many analysts on Wall Street think the pharmaceutical stock can climb a lot higher. Bank of …

msn.com

FAQs about The Weight-Loss Battle That Could Rattle Eli Lilly's $100 Billion … Coupon?

Will Eli Lilly stock triple over the next 5 years?

Revenue from Eli Lilly 's ( LLY) weight-loss drug is expected to triple over the next five years. Those lofty Wall Street views have lifted Eli Lilly stock to a record high, as the stock is up 49% this year alone. ...

Is Eli Lilly a good stock to buy?

Eli Lilly has seen explosive share price growth over the past year. Its weight loss and diabetes treatments are growing sales rapidly, but it's not resting on its laurels. Lilly's ability to stay ahead of the game can allow it to keep winning going forward. In a year and a half, Eli Lilly (NYSE: LLY) has roughly doubled in value. ...

Why did Eli Lilly share prices fall?

Eli Lilly shares fell sharply in early Wednesday trading after the pharmaceutical giant posted weaker-than-expected third-quarter earnings, while slashing its full-year profit forecast, following disappointing sales of its blockbuster weight loss treatments. ...

How much money does Eli Lilly make a year?

Eli Lilly’s two weight loss drugs have become blockbusters, bringing in more than $1 billion in annual revenue. Demand is growing in this market, but so is competition. Eli Lilly is focusing on research and manufacturing. Eli Lilly (LLY -3.68%) is a leader in one of the pharmaceutical industry's highest-growth markets: weight loss drugs. ...

Is Eli Lilly bolstering its pipeline beyond weight-loss drugs?

Eli Lilly is also bolstering its pipeline beyond weight-loss drugs. Shares broke out on May 21 on promising results for a Crohn's disease treatment, mirikizumab. After a year, more than half of patients who took Lilly's drug entered remission. ...

How did zepbound Impact Eli Lilly's fourth-quarter earnings report?

Zepbound played an important role in Eli Lilly's fourth-quarter earnings report as the Indianapolis, IND.-based company beat Wall Street's expectations, leading analysts to revamp their stock price targets. Eli Lilly's sales surged thanks to demand for weight-loss drugs Mounjaro and Zepbound. ...

Install CouponFollow Extension on Chrome

Install the CouponFollow extension to search for discount codes when shopping the fastest!

Install CouponFollow Chrome Extension   Install CouponFollow Chrome Extension